These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 2643225
1. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival. Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. Transplantation; 1989 Jan; 47(1):177-81. PubMed ID: 2643225 [Abstract] [Full Text] [Related]
2. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI, Cofer BR, Davies C, Alexander JW. Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575 [Abstract] [Full Text] [Related]
3. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. Brunson ME, Tchervenkov JI, Alexander JW. Transplantation; 1991 Sep 27; 52(3):545-9. PubMed ID: 1716800 [Abstract] [Full Text] [Related]
4. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival. Oluwole SF, Lau HT, Reemtsma K, Hardy MA. Transplantation; 1988 Feb 27; 45(2):293-7. PubMed ID: 3278417 [Abstract] [Full Text] [Related]
5. Augmentation of donor-specific transfusion and cyclosporine effects with dietary linoleic acid. Perez RV, Munda R, Alexander JW. Transplantation; 1989 Jun 27; 47(6):937-40. PubMed ID: 2660353 [Abstract] [Full Text] [Related]
6. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization. Martinelli GP, Horowitz C, Chiang K, Racelis D, Schanzer H. Transplantation; 1987 Jan 27; 43(1):140-5. PubMed ID: 3541314 [Abstract] [Full Text] [Related]
7. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine. Oluwole SF, Fawwaz RA, Reemtsma K, Hardy MA. Transplantation; 1988 Jun 27; 45(6):1131-5. PubMed ID: 3289153 [Abstract] [Full Text] [Related]
8. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival. Davies CB, Madden RL, Alexander JW, Cofer BR, Fisher RA, Anderson P. Transplantation; 1993 May 27; 55(5):1107-12. PubMed ID: 8497890 [Abstract] [Full Text] [Related]
9. Arginine, fish oil, and donor-specific transfusions independently improve cardiac allograft survival in rats given subtherapeutic doses of cyclosporin. Alexander JW, Levy A, Custer D, Valente JF, Babcock G, Ogle CK, Schroeder TJ. JPEN J Parenter Enteral Nutr; 1998 May 27; 22(3):152-5. PubMed ID: 9586793 [Abstract] [Full Text] [Related]
10. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion. Gibson SW, Valente JF, Alexander JW, Custer DA, Babcock GF, Ogle CK. J Heart Lung Transplant; 1999 Mar 27; 18(3):185-9. PubMed ID: 10328142 [Abstract] [Full Text] [Related]
11. Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat. Knight RJ, Polokoff EG, Martinelli GP. Transplantation; 1994 Nov 15; 58(9):1014-20. PubMed ID: 7974728 [Abstract] [Full Text] [Related]
12. The significance of timing of additional short-term immunosuppression in the donor-specific transfusion/cyclosporine-treated rat. Levy AE, Alexander JW. Transplantation; 1996 Jul 27; 62(2):262-6. PubMed ID: 8755826 [Abstract] [Full Text] [Related]
13. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine. Levy AE, Alexander JW. Transplantation; 1995 Oct 27; 60(8):812-5. PubMed ID: 7482740 [Abstract] [Full Text] [Related]
14. Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival. Martinelli GP, Knight RK, Kaplan S, Racelis D, Dikman SH, Schanzer H. Transplantation; 1988 Jun 27; 45(6):1021-6. PubMed ID: 3260047 [Abstract] [Full Text] [Related]
15. A comparison between pancreas and heart allotransplantation after administration of donor-specific antigen and cyclosporine. Cooke JC, McBride JL, Schulak JA. Transplantation; 1989 Jul 27; 48(1):15-9. PubMed ID: 2473549 [Abstract] [Full Text] [Related]
16. A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts. Levy AE, Alexander JW, Babcock GF. Transpl Immunol; 1997 Jun 27; 5(2):83-8. PubMed ID: 9269029 [Abstract] [Full Text] [Related]
17. Effects of pre- and postengraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival. Cofer BR, Davies CB, Alexander JW, Tchervenkov JI, Fisher RA. J Surg Res; 1992 Jun 27; 52(6):663-7. PubMed ID: 1528044 [Abstract] [Full Text] [Related]
19. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine. Martinelli GP, Chung-Loy R, Sher L, Racelis D, Miller CM, Schanzer H. Transplantation; 1985 Jan 27; 39(1):1-5. PubMed ID: 3880956 [Abstract] [Full Text] [Related]
20. Elimination of acute GVHD and prolongation of rat pancreas allograft survival with DST cyclosporine, and spleen transplantation. Wakely E, Oberholser JH, Corry RJ. Transplantation; 1990 Feb 27; 49(2):241-5. PubMed ID: 2305452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]